AMERICA MOVIL SAB DE CV/

Where It Passes

Where It Falls Short

• Valuation0% pass✓ 1✗ 27▾

  No clean pass — all 13 investors flag at least one valuation criterion

  Price / 3-yr avg EPS

  ✗Graham<= 15x

  Price-to-Book Ratio86.9x

  ✗Graham<= 1.5x

  P/E x P/B

  ✗Graham<= 22.5

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  EBIT / Enterprise Value8.6%

  ✗Greenblatt> 10%

  Earnings Yield + ROC AssessmentEY=8.6%, ROC=28.1%

  ✗GreenblattBoth EY > 10% and ROC > 25%

  Price / EPS

  ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)

  Price / (CFO / Shares)133.9x

  ✗Dreman< 8x

  Price / Book Value per Share86.9x

  ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)

  Valuation ReasonablenessOE Yield=0.2%

  ✗MungerP/E < 25 or Owner Earnings Yield > 5%

  P/E or FCF YieldFCF Yield=8.0%

  ✗PabraiP/E < 15 or FCF Yield > 10%

  P/B or P/E vs. Historical AverageP/B=86.9x

  ✗MarksP/E < 15 or P/B < 2.0

  Discount to Intrinsic Value

  ✗Marks>= 20% below intrinsic value

  Price / FCF per Share253.9x

  ✗Ackman<= 25

  Price vs. Trailing Low182% of trailing low ($14.01)

  ✗Templeton<= 120% of trailing low (certified split-adjusted live window)

  Net income / market capitalization+1.46%; #2860/6340 (top 45.1%)

  ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section

  Positive book equity / market capitalization+0.2353; #4003/6449 (top 62.1%)

  ✗AsnessTop 30% of eligible cross-section

  Price / Diluted EPS

  ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)

  (EPS CAGR % + Dividend Yield %) / P/E

  ✗Neff> 0.7 (Neff's published traditional edge)

  Price / Tangible Book Value per Share454.61x

  ✗SchlossP/TBV <= 1.00x (app cutoff)

  Book Value per Share Change+105.8%

  ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)

  Revenue / market capitalization+0.5541; #2483/5247 (top 47.3%)

  ✗OshaughnessyTop 10% of eligible cross-section

  (Operating cash flow - capex) / market capitalization+8.05%; #999/4519 (top 22.1%)

  ✗OshaughnessyTop 10% of eligible cross-section

  Trailing six-month price return through the evaluation date+0.35%; #2652/6202 (top 42.8%)

  ✗OshaughnessyTop 10% of eligible cross-section
• Valuation models0% pass✗ 7▾

  AMX overvalued: all 7 models price fair value below $25.47 (median $1.25)

  Buffett fair value$1.45

  ✗Buffett-1656.6% margin vs $25.47

  Greenblatt fair value$1.18

  ✗Greenblatt-2058.5% margin vs $25.47

  Munger fair value$1.25

  ✗Munger-1937.6% margin vs $25.47

  Pabrai fair value$0.27

  ✗Pabrai-9333.3% margin vs $25.47

  Akre fair value$2.20

  ✗Akre-1057.7% margin vs $25.47

  Marks fair value$0.47

  ✗Marks-5319.1% margin vs $25.47

  Ackman fair value$1.97

  ✗Ackman-1192.9% margin vs $25.47
• Profitability6% pass✓ 11✗ 24▾

  15 of 16 flag AMX's profitability — Graham, Buffett, Lynch +12 more

  Positive EPS (10 years)6/11 years positive

  ✗GrahamPositive EPS every year for 10 years

  EPS Growth (3-yr avg, 10-yr window)

  ✗Graham>= 33% growth

  Net Income Positive (10+ years)10/11 years positive

  ✗BuffettPositive every year for 10+ years

  ROE (up to 5-year arithmetic mean)23.1%

  ✓Buffett> 15% arithmetic mean (app rule)

  Operating Margin (10-yr trend)20.7% (latest)

  ✓BuffettStable or rising over 10 years

  Free Cash Flow Proxy$3.6B

  ✓BuffettPositive and growing

  Earnings Variance (10-yr CoV)0.47

  ✗BuffettCoV < 0.3

  Retained Earnings Effectiveness

  ✗Buffett$1 retained -> > $1 market value created

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  3-5 Year EPS CAGR3.5%

  ✓Lynch15-30% (Fast Grower); > 0% to pass

  ROE6.2%

  ✗Lynch> 15%

  EBIT / Enterprise Value8.6%

  ✗Greenblatt> 10%

  Earnings Yield + ROC AssessmentEY=8.6%, ROC=28.1%

  ✗GreenblattBoth EY > 10% and ROC > 25%

  Net Income / Total Assets1.28%

  ✓PiotroskiROA > 0

  ROA Change YoY4.87% -> 1.28% (delta: -3.59%)

  ✗PiotroskiCurrent ROA > Prior ROA

  (CFO / Total Assets) vs ROACFO/Assets=13.34%, ROA=1.28%

  ✓PiotroskiCFO/Assets > ROA

  Gross Margin Change YoY61.2% -> 61.9%

  ✓PiotroskiImproved YoY

  Pre-Tax Income / Revenue7.2%

  ✗Dreman>= 8%

  Net Income / Shareholders' Equity6.2%

  ✗Dreman> 12%

  Margin of SafetyP/B=86.9x

  ✗PabraiP/B < 1.5 or P/E < 15

  Return on Equity15.8% (3-yr avg)

  ✗AkreROE > 20% (3-year avg)

  Discount to Intrinsic Value

  ✗Marks>= 20% below intrinsic value

  Positive Net Income Frequency10/10 years positive

  ✓MarksPositive net income in >= 7 of last 10 years

  Operating Income / Revenue20.7%

  ✓Ackman>= 15%

  Net Income / Shareholders Equity6.2%

  ✗Ackman>= 15%

  5-Year EPS CAGR

  ✗Templeton> 0% (5-year EPS CAGR)

  Operating Margin Trend20.2% (2022) -> 20.7% (2024)

  ✓TempletonNon-negative operating-margin trend over 3 years

  Revenue growth vs. gross and operating margin trendgross margin 60.9% -> 61.9%, operating margin 20.2% -> 20.7%

  ✗SleepRevenue rising; gross margin flat or falling; operating margin holding

  Net income / market capitalization+1.46%; #2860/6340 (top 45.1%)

  ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section

  Gross profit / total assets+29.99%; #1432/3702 (top 38.7%)

  ✗AsnessTop 30% of eligible cross-section

  Net income / positive book equity+6.21%; #2309/5226 (top 44.2%)

  ✗AsnessTop 30% of eligible cross-section

  Negative 5-year standard deviation of ROA-0.0344; #2087/5884 (top 35.5%)

  ✗AsnessTop 30% of eligible cross-section

  3-5 Year Diluted EPS CAGR3.5% over 5 years

  ✗Neff7%-20% annualized

  Positive Diluted-EPS Years6/6 years positive

  ✓Schloss>= 70% positive over 5-10 observed years (app rule)
• Debt & Leverage8% pass✓ 1✗ 14▾

  11 of 12 flag AMX's debt & leverage — Graham, Buffett, Lynch +8 more

  LT Debt vs Net Current AssetsLT Debt $22.5B vs NCA $-6.8B

  ✗GrahamLT Debt <= Net Current Assets

  Debt/Equity & Interest CoverageD/E: 1.54, IC: 3.2x

  ✗BuffettD/E < 0.5 AND Interest Coverage > 5x

  Total Debt / Equity1.54

  ✗Lynch< 0.33

  Cash - Long-term Debt$-20.7B

  ✗LynchPositive preferred

  LT Debt / Total Assets Change21.72% -> 25.83%

  ✗PiotroskiDecreased YoY

  Current Assets / Current Liabilities0.72

  ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)

  Total Debt / Shareholders' Equity1.54

  ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x

  Debt Levels1.54

  ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3

  Interest Coverage & Debt/EBITDAIC=3.2x, D/EBITDA=1.6x

  ✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x

  Total Debt / Shareholders Equity1.54

  ✗Ackman<= 1.0

  Negative debt-to-equity (higher means less debt)-1.5378; #3613/4210 (top 85.8%)

  ✗AsnessTop 30% of eligible cross-section
• Growth13% pass✓ 4✗ 9▾

  7 of 8 flag AMX's growth — Graham, Lynch, Dreman +4 more

  EPS Growth (3-yr avg, 10-yr window)

  ✗Graham>= 33% growth

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  3-5 Year EPS CAGR3.5%

  ✓Lynch15-30% (Fast Grower); > 0% to pass

  Inventory Growth vs Revenue GrowthInv: 1.3% vs Rev: -12.5%

  ✗LynchInventory growth < Revenue growth

  EPS Growth Direction$0.03 (2015) -> $0.04 (2020)

  ✓DremanPositive over recent years

  EPS CAGR3.5% CAGR over 5 years

  ✗Dreman> 5% annualized

  Positive Net Income Frequency10/10 years positive

  ✓MarksPositive net income in >= 7 of last 10 years

  3yr Median Revenue Growth6.9%

  ✓Ackman>= 5%

  Positive EPS Growth Frequency0/1 years with positive EPS growth

  ✗AckmanPositive EPS growth in >= 3 of last 5 years

  5-Year EPS CAGR

  ✗Templeton> 0% (5-year EPS CAGR)

  Revenue growth vs. gross and operating margin trendgross margin 60.9% -> 61.9%, operating margin 20.2% -> 20.7%

  ✗SleepRevenue rising; gross margin flat or falling; operating margin holding

  5-year Revenue CAGR-1.3%

  ✗SleepCAGR > 7%

  3-5 Year Diluted EPS CAGR3.5% over 5 years

  ✗Neff7%-20% annualized
• Verdicts31% pass✓ 5✗ 11▾

  Split decision: 11 FAIL · 4 PASS · 1 NEUTRAL

  Overall verdict

  ✗GrahamFAIL (1/9)✓BuffettPASS (5/9)✗LynchFAIL (1/7)✓GreenblattRank #549•PiotroskiNEUTRAL (F-Score 6)✗DremanFAIL (2/11)✓MungerPASS (2/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (3/5)✓AckmanPASS (4/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #1540/2370 (Top 65.0%))✗NeffFAIL (2/6)✗SchlossFAIL (3/7)✗OshaughnessyFAIL (Rank #321/963 (Top 33.3%))
• Cash Flow50% pass✓ 6✗ 6▾

  5 of 10 pass — Lynch, Dreman, Pabrai +2 more object

  Free Cash Flow Proxy$3.6B

  ✓BuffettPositive and growing

  FCF Positive and Growing$6.1B

  ✗LynchPositive and growing

  Operating Cash Flow$11.6B

  ✓PiotroskiCFO > 0

  (CFO / Total Assets) vs ROACFO/Assets=13.34%, ROA=1.28%

  ✓PiotroskiCFO/Assets > ROA

  Price / (CFO / Shares)133.9x

  ✗Dreman< 8x

  P/E or FCF YieldFCF Yield=8.0%

  ✗PabraiP/E < 15 or FCF Yield > 10%

  FCF Positive10/10 years FCF positive

  ✓MarksPositive FCF in majority of recent years

  (OCF - CapEx) / Market Cap0.4%

  ✗Ackman>= 4%

  Price / FCF per Share253.9x

  ✗Ackman<= 25

  Positive Operating Cash Flow frequency10/10 years positive

  ✓SleepPositive OCF in >= 70% of available years

  Operating Cash Flow - Capital Expenditures$6.1B

  ✓Neff> $0 (app proxy for a strong fundamental case)

  (Operating cash flow - capex) / market capitalization+8.05%; #999/4519 (top 22.1%)

  ✗OshaughnessyTop 10% of eligible cross-section
• Efficiency50% pass✓ 7✗ 4▾

  4 of 8 pass — Graham, Piotroski, Dreman +1 more object

  Current Ratio0.72

  ✗Graham>= 2.0

  ROIC (3-5 yr avg)15.2%

  ✓Buffett> 10%

  ROIC - WACC+5.2%

  ✓BuffettPositive (WACC = 10%)

  EBIT / (NWC + Net Fixed Assets)28.1%

  ✓Greenblatt> 25%

  Current Ratio Change YoY0.65 -> 0.72

  ✓PiotroskiIncreased YoY

  Revenue / Total Assets Change YoY0.52x -> 0.48x

  ✗PiotroskiImproved YoY

  Current Assets / Current Liabilities0.72

  ✗Dreman> 1.5

  Return on Invested Capital15.2%

  ✓Munger> 15%

  ROIC (high and growing)FY2022: ROIC=15.3%; FY2023: ROIC=15.3%; FY2024: ROIC=15.2%

  ✓AkreLatest 3 consecutive FYs: ROIC > 15% in each

  Reinvestment Rate x ROIC0.0% (RR=0% x ROIC=15.2%)

  ✗AkreReinvestment Rate * ROIC > 10%

  ROIC (5-year)5/5 years above 12% (latest 15.2%)

  ✓SleepROIC > 12% in a majority of years